Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: The Immune Directed Individualized Elimination Therapy (iDIET) Study [NA]

View source ↗

Summary

This clinical trial update describes the iDIET study sponsored by the University of North Carolina at Chapel Hill, investigating treatment for eosinophilic esop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Eosinophilic Esophagitis, EoE | NA | Status: ACTIVE_NOT_RECRUITING